Cargando…

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay

Globally, malignant melanoma shows a steady increase in the incidence among cancer diseases. Malignant melanoma represents a cancer type where currently no biomarker or diagnostics is available to identify disease stage, progression of disease or personalized medicine treatment. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welinder, Charlotte, Jönsson, Göran B., Ingvar, Christian, Lundgren, Lotta, Baldetorp, Bo, Olsson, Håkan, Breslin, Thomas, Rezeli, Melinda, Jansson, Bo, Fehniger, Thomas E., Laurell, Thomas, Wieslander, Elisabet, Pawlowski, Krzysztof, Marko-Varga, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204935/ https://www.ncbi.nlm.nih.gov/pubmed/25333933 http://dx.doi.org/10.1371/journal.pone.0110804

Ejemplares similares

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
por: Welinder, Charlotte, et al.
Publicado: (2013)

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
por: Welinder, Charlotte, et al.
Publicado: (2015)

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017)

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011)

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
por: Sanchez, Aniel, et al.
Publicado: (2019)

Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
por: Malm, Johan, et al.
Publicado: (2013)

Clinical protein science in translational medicine targeting malignant melanoma
por: Gil, Jeovanis, et al.
Publicado: (2019)

Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
por: Kim, Yonghyo, et al.
Publicado: (2020)

Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
por: Gidlöf, Olof, et al.
Publicado: (2019)

Primary Breast Cancer Tumours Contain High Amounts of IgA1 Immunoglobulin: An Immunohistochemical Analysis of a Possible Carrier of the Tumour-Associated Tn Antigen
por: Welinder, Charlotte, et al.
Publicado: (2013)

Biobank resources for future patient care: developments, principles and concepts
por: Végvári, Ákos, et al.
Publicado: (2011)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies
por: Eriksson, Jonatan, et al.
Publicado: (2017)

Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study
por: Truedsson, Mikael, et al.
Publicado: (2016)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Test and evaluation of SRM implementations
por: Donno, Flavia, et al.
Publicado: (2008)

SOS Routing Module (SRM)
por: Kenaghan, J.
Publicado: (1982)

Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies
por: Malm, Johan, et al.
Publicado: (2015)

SRM and GFAL Testing for LCG2
por: Slabospitskaya, E, et al.
Publicado: (2005)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2021)

The human melanoma proteome atlas—Defining the molecular pathology
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2021)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

CASTOR SRM v1.1 experience
por: Bärring, O
Publicado: (2004)

WLCG space accounting in the SRM-less world
por: Andreeva, Julia, et al.
Publicado: (2019)

In silico design of targeted SRM-based experiments
por: Nahnsen, Sven, et al.
Publicado: (2012)

Building the basis for proteomics in personalized medicine for targeted treatment
por: Kwon, Ho Jeong, et al.
Publicado: (2016)

MRMPlus: an open source quality control and assessment tool for SRM/MRM assay development
por: Aiyetan, Paul, et al.
Publicado: (2015)

Expediting SRM Assay Development for Large-Scale Targeted Proteomics Experiments
por: Wu, Chaochao, et al.
Publicado: (2014)

SRM 2.2 Service Deployment Schedule & Issues
por: Ressmann, Doris, et al.
Publicado: (2007)

An HTTP Rest API as SRM replacement for tape access
por: Caffy, Cedric
Publicado: (2022)

SRM 2460/2461 Standard Bullets and Casings Project
por: Song, J., et al.
Publicado: (2004)

SRM-MS Method Development for Hepcidin-25 Peptide
por: Cho, Kyung-Cho, et al.
Publicado: (2018)

Certification of SRM1960: Nominal 10 μm Diameter Polystyrene Spheres (“Space Beads”)
por: Lettieri, Thomas R., et al.
Publicado: (1991)

Clusterwise Peak Detection and Filtering Based on Spatial Distribution To Efficiently Mine Mass Spectrometry Imaging Data
por: Eriksson, Jonatan O., et al.
Publicado: (2019)

Re-Analysis of the Uncertainty of the 0.895 µm Diameter (NIST SRM(®) 1690) and the 0.269 µm Diameter (NIST SRM(®) 1691) Sphere Standards
por: Mulholland, G. W.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_0sca9rh7g8t69fr3pldls05058